513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arrowhead Pharmaceuticals reported a fiscal 2024 net loss attributable to the company of $599.5 million, or $5.00 per diluted share, for the year ended September 30, 2024, compared with a loss of $205.3 million, or $1.92 per share, a year earlier. Revenue fell to $3.6 million from $240.7 million, while research and development expense rose to $505.9 million from $353.2 million. The company said its recent Sarepta licensing deal and Sixth Street credit facility, both announced in the filing period, extend its cash runway into 2028.
Revenue was $3.6 million in fiscal 2024 versus $240.7 million in fiscal 2023.
Diluted net loss per share was $5.00 versus $1.92 a year earlier.
Research and development expense was $505.9 million versus $353.2 million.
Sarepta agreement provides $825 million upon closing, including a $325 million equity investment; Sixth Street facility is $500 million, with $400 million funded at close.
HP reported fiscal 2024 results for the year ended October 31, 2024, with net revenue of $53.6 billion, down 0.3%, and GAAP diluted EPS of $2.81, down from $3.26 a year earlier but above its previously provided outlook. Fourth-quarter net revenue rose 1.7% to $14.1 billion, and the board raised the quarterly dividend 5% to $0.2894 per share. HP's fiscal 2025 non-GAAP diluted EPS outlook is $3.45 to $3.75, compared with $3.38 in fiscal 2024.
Fiscal 2024 net revenue was $53.6 billion, down 0.3%; GAAP diluted EPS was $2.81 versus $3.26 in fiscal 2023
Fourth-quarter net revenue was $14.1 billion, up 1.7%; non-GAAP diluted EPS was $0.93 versus $0.90
Quarterly dividend increased 5% to $0.2894 per share, payable January 2, 2025 to holders of record as of December 11, 2024
Fiscal 2025 outlook: non-GAAP diluted EPS of $3.45 to $3.75 and free cash flow of $3.2 billion to $3.6 billion
For the quarter ended October 31, 2024, J.M. Smucker reported net sales of $2.3 billion, up 17% mainly due to the Hostess Brands acquisition, and adjusted earnings per share of $2.76, up 7%. The company posted a GAAP net loss of $0.23 per diluted share, versus earnings of $1.90 a year earlier, after a $260.8 million pre-tax loss on the Voortman business held for sale. The company raised its full-year fiscal 2025 adjusted earnings per share guidance to $9.70 to $10.10 from $9.60 to $10.00.
Net sales were $2.3 billion, up $332.6 million or 17%; excluding the acquisition, divestitures, and currency, net sales rose 2%.
GAAP net loss of $0.23 per diluted share, compared with $1.90 a year earlier, including a $260.8 million pre-tax loss on the Voortman business.
Adjusted earnings per share were $2.76, up 7%; free cash flow was $317.2 million versus $28.2 million a year earlier.
Fiscal 2025 adjusted earnings per share guidance raised to $9.70 to $10.10 from $9.60 to $10.00; net sales growth guidance unchanged at 8.5% to 9.5%.
Burlington reported third-quarter fiscal 2024 total sales up 11% to $2,526 million and net income of $91 million, or $1.40 per diluted share, versus $49 million, or $0.75, a year earlier. The company raised its full-year fiscal 2024 adjusted EPS guidance to $7.76 to $7.96, but comparable store sales grew only 1%, and its fourth-quarter guidance calls for a lower adjusted EBIT margin.
Q3 total sales rose 11% to $2,526 million; comparable store sales rose 1%, which management attributed to warmer weather from mid-September.
Q3 net income was $91 million, or $1.40 per diluted share; adjusted EPS rose 41% to $1.55.
Full-year fiscal 2024 adjusted EPS guidance was raised to $7.76 to $7.96.
Fourth-quarter guidance calls for comparable store sales growth of 0% to 2% and an adjusted EBIT margin decline of 50 to 80 basis points.
New Jersey Resources reported fiscal 2024 net income of $289.8 million, or $2.94 per share, up from $2.73 per share a year earlier, with net financial earnings per share of $2.95 at the higher end of its guidance range. It introduced fiscal 2025 guidance of $3.05 to $3.20 per share, which it said is above its long-term growth target because of a one-time gain from the $132.5 million sale of its residential solar portfolio, closed November 25, 2024. Fiscal 2024 operating revenues fell to $1.8 billion from $2.0 billion, and the company raised its fiscal 2025 dividend 7.1 percent to $1.80 per share.
Fiscal 2024 net income was $289.8 million, or $2.94 per share, compared with $264.7 million, or $2.73 per share, in fiscal 2023.
Fiscal 2024 net financial earnings were $290.8 million, or $2.95 per share, at the higher end of guidance raised in February 2024.
Fiscal 2025 net financial earnings per share guidance is $3.05 to $3.20; the dividend rises 7.1 percent to $1.80 per share.
The residential solar portfolio sale closed November 25, 2024 for approximately $132.5 million, subject to adjustments; the company expects a gain in fiscal 2025.
Semtech reported third quarter fiscal 2025 results for the quarter ended October 27, 2024, with net sales of $236.8 million, up 10% from the prior quarter, and a GAAP diluted loss of $0.10 per share, compared with a $2.61 loss per share in the prior quarter. The company also guided fourth quarter net sales to $250.0 million, plus or minus $5.0 million, and non-GAAP diluted earnings per share to $0.32, plus or minus $0.03.
Net sales of $236.8 million, up 10% from $215.4 million in the prior quarter
Record data center net sales of $43.1 million, up 58% from the prior quarter
GAAP diluted loss of $0.10 per share vs. a $2.61 loss per share in the prior quarter; non-GAAP diluted EPS of $0.26
Fourth quarter fiscal 2025 outlook: net sales of $250.0 million, plus or minus $5.0 million; non-GAAP diluted EPS of $0.32, plus or minus $0.03
Woodward reported fiscal 2024 net sales of $3.3 billion, up 14%, and diluted EPS of $6.01, up 59%, for the year ended September 30, 2024. For fiscal 2025 it guided to sales of $3.30 billion to $3.50 billion and EPS of $5.75 to $6.25, with Industrial sales expected to fall 7% to 11% due to lower China on-highway natural gas truck sales.
Fiscal 2024 net sales $3.3 billion (+14%); fourth quarter net sales $855 million (+10%)
Central Garden & Pet reported fiscal 2024 net sales of $3.2 billion, down 3% from $3.3 billion, with GAAP diluted EPS of $1.62 versus $1.88 a year earlier and non-GAAP diluted EPS of $2.13 versus $2.07. The company expects fiscal 2025 non-GAAP EPS of $2.20 or better, while fourth-quarter results included a net loss of $34 million.
Fiscal 2024 net sales were $3.2 billion, down 3%; organic net sales fell 4%.
Fourth-quarter net sales were $669 million, down 11%, and the company posted a GAAP net loss of $34 million, or $0.51 per diluted share.
Fiscal 2025 non-GAAP EPS is expected to be $2.20 or better, according to the company's outlook.
Cash and cash equivalents were $754 million at September 28, 2024, compared with $489 million a year earlier.
Bath & Body Works reported third-quarter 2024 net sales of $1,610 million, up 3.0%, but diluted earnings per share fell to $0.49 from $0.52 a year earlier. The company raised its full-year 2024 earnings and net sales guidance, while its fourth-quarter outlook calls for net sales to decline 4.5% to 6.5% and earnings per share of $1.94 to $2.07 versus $2.55 a year earlier.
Q3 2024 net sales were $1,610 million, up 3.0% from $1,562 million; net income was $106 million versus $119 million
Q3 diluted EPS was $0.49 versus $0.52; adjusted EPS was $0.49 versus $0.48 after excluding a 2023 debt-extinguishment gain
Full-year 2024 GAAP EPS guidance raised to $3.46 to $3.59, including $400 million of planned share repurchases
Fourth-quarter 2024 net sales expected to decline 6.5% to 4.5%, with EPS of $1.94 to $2.07 versus $2.55 in Q4 2023
Buckle reported third-quarter fiscal 2024 results for the quarter ended November 2, 2024. Net sales fell 3.2% to $293.6 million and net income fell to $44.2 million, or $0.88 per diluted share, from $51.8 million, or $1.04 per diluted share, a year earlier. Both headline measures declined, which weighs on shareholders, though online sales rose 1.1%.
Net sales for the quarter decreased 3.2% to $293.6 million from $303.5 million; comparable store net sales decreased 0.7%.
Online sales rose 1.1% to $46.6 million for the quarter.
Quarterly net income was $44.2 million, or $0.89 per share ($0.88 diluted), versus $51.8 million, or $1.05 per share ($1.04 diluted), a year earlier.
Year-to-date net income was $118.3 million, or $2.37 per share ($2.35 diluted), versus $140.3 million for the prior-year period.
IES Holdings reported fiscal fourth-quarter 2024 revenue of $776 million, up 20%, and net income attributable to the company of $63.1 million, up 67%, with diluted earnings per share of $3.06 versus $1.66 a year earlier. For fiscal 2024, revenue rose 21% to $2.9 billion and diluted earnings per share were $9.89 versus $4.54. The filing also disclosed special cash bonuses for executive officers and a new incentive plan for fiscal 2025 tied to adjusted income.
Q4 operating income was $75.0 million, up 41% from $53.2 million; fiscal 2024 operating income was $300.9 million, up 88%
At September 30, 2024, the company reported no debt and cash of $100.8 million
On November 21, 2024, the compensation committee approved special bonuses, including $2,285,000 for President and COO Matthew Simmes and $1,500,000 for Chairman and CEO Jeffrey Gendell
Management said the Commercial & Industrial segment's revenue is expected to decline in the first quarter of fiscal 2025 after a large data center project was substantially completed
Gap Inc. reported third-quarter fiscal 2024 net sales of $3.8 billion, up 2%, and operating income of $355 million, compared with $250 million a year earlier. The company raised its full-year fiscal 2024 outlook for net sales, gross margin and operating income growth.
Diluted earnings per share were $0.72, compared with $0.58 a year earlier; net income was $274 million.
Comparable sales rose 1%, and operating margin was 9.3%, up 270 basis points.
Full-year operating income growth outlook was raised to the mid to high 60% range, from the mid to high 50% range.
Full-year net sales growth outlook is now up 1.5% to 2.0% on a 52-week basis, from up slightly.
Copart reported first-quarter fiscal 2025 results for the period ended October 31, 2024, with revenue up 12.4% to $1.15 billion and net income attributable to Copart up 8.9% to $362.1 million. Diluted earnings per share rose 8.8% to $0.37, which gives shareholders a year-over-year gain in both sales and profit.
Revenue of $1.15 billion, up $126.4 million or 12.4% from the same period last year
Gross profit of $512.1 million, up $48.1 million or 10.4%
Net income attributable to Copart of $362.1 million, up $29.6 million or 8.9%
Fully diluted EPS of $0.37 versus $0.34 a year earlier, an increase of 8.8%
Intuit reported fiscal first-quarter 2025 results for the period ended October 31, 2024, with revenue up 10% to $3.3 billion while GAAP diluted earnings per share fell 18% to $0.70. Non-GAAP diluted EPS rose 1% to $2.50. The company reiterated its full fiscal 2025 guidance and approved a quarterly dividend of $1.04 per share, up 16% from a year earlier.
Revenue of $3.3 billion, up 10%; Global Business Solutions Group revenue of $2.5 billion, up 9%; Credit Karma revenue of $524 million, up 29%.
GAAP operating income fell 12% to $271 million, including a $9 million restructuring charge and a $42 million net loss on a private company investment.
Full fiscal 2025 guidance reiterated; second-quarter guidance calls for revenue of $3.812 billion to $3.845 billion and non-GAAP diluted EPS of $2.55 to $2.61.
Quarterly dividend of $1.04 per share payable January 17, 2025, to holders of record as of January 9, 2025.
NetApp reported second-quarter fiscal 2025 results for the quarter ended October 25, 2024, with net revenues up 6% and GAAP net income per share of $1.42, compared with $1.10 a year earlier. The company also issued third-quarter fiscal 2025 guidance and an update to its full-year fiscal 2025 guidance. For shareholders, revenue and profit grew, though cash provided by operations fell to $105 million from $135 million.
Net revenues were $1.66 billion, up from $1.56 billion, and billings rose 9% to $1.59 billion.
GAAP net income per share was $1.42 versus $1.10; non-GAAP net income per share was $1.87 versus $1.58.
Third-quarter fiscal 2025 guidance: net revenues of $1.610 billion to $1.760 billion and non-GAAP EPS of $1.85 to $1.95.
Full-year fiscal 2025 guidance: net revenues of $6.540 billion to $6.740 billion and non-GAAP EPS of $7.20 to $7.40.
Ross Stores reported third-quarter earnings per share of $1.48 for the 13 weeks ended November 2, 2024, up from $1.33, on sales of $5.1 billion, up from $4.9 billion, with comparable store sales up 1%. The company said sales were below plan, but it now expects fiscal 2024 earnings per share of $6.10 to $6.17, compared with $5.56 last year, and fourth-quarter earnings per share of $1.57 to $1.64, compared with $1.82 for the prior-year fourth quarter.
Q3 diluted EPS $1.48 vs. $1.33 a year earlier; net earnings $489 million vs. $447 million
Q3 sales $5.1 billion vs. $4.9 billion; operating margin 11.9% vs. 11.2%
Fourth-quarter EPS guidance $1.57 to $1.64 vs. $1.82 last year, including about $0.03 unfavorable packaway timing impact
Fiscal 2024 EPS now expected at $6.10 to $6.17 vs. $5.56 last year; $1.05 billion buyback planned for fiscal 2024
Construction Partners reported fiscal 2024 results for the year ended September 30, 2024, with full-year revenue up 17%, net income up 41% and Adjusted EBITDA up 28% from fiscal 2023. Fourth-quarter net income fell 5.2% even as quarterly revenue rose 13%, and the company said fiscal 2025 outlook is unchanged from what it previously announced, with the Lone Star Paving acquisition expected to contribute eleven months of results.
Fiscal 2024 revenue was $1.82 billion, up 17% from $1.56 billion; net income was $68.9 million, up 41%.
Fourth-quarter revenue was $538.2 million, up 13%, while fourth-quarter net income was $29.3 million, down 5.2%.
Project backlog was a record $1.96 billion at September 30, 2024, compared with $1.60 billion a year earlier.
Fiscal 2025 outlook: revenue of $2.48 billion to $2.58 billion and net income of $97 million to $113 million, as previously announced.
BJ's Wholesale Club reported third-quarter fiscal 2024 results, with total revenues up 3.5% to $5.10 billion and diluted EPS of $1.17 versus $0.97 a year earlier. The company raised its full-year adjusted EPS range to $3.90 to $4.00 from a previously stated $3.75 to $4.00 range, and approved a new $1.0 billion share repurchase program.
Q3 fiscal 2024 total revenues were $5.10 billion, up 3.5%; diluted EPS was $1.17 versus $0.97, and adjusted EPS was $1.18 versus $1.00
Full-year fiscal 2024 adjusted EPS range raised to $3.90 to $4.00; comparable club sales growth now expected at 2.3% to 2.4%
Board approved a $1.0 billion share repurchase program on November 18, 2024, expiring January 2029
Club membership fee rises $5 to $60 a year and Club+ rises $10 to $120 a year, effective January 1, 2025
Maximus reported fiscal 2024 revenue of $5.31 billion, up 8.2% from $4.90 billion, and diluted earnings per share of $4.99, up from $2.63. The company also set fiscal 2025 guidance calling for revenue of $5.275 billion to $5.425 billion and adjusted diluted EPS of $5.70 to $6.00, and declared a $0.30 quarterly dividend.
FY2024 revenue rose 8.2% to $5.31 billion; organic growth was 8.8%
FY2024 diluted EPS was $4.99 versus $2.63; adjusted diluted EPS was $6.11 versus $3.83
FY2025 guidance: revenue of $5.275 billion to $5.425 billion; adjusted diluted EPS of $5.70 to $6.00
Quarterly dividend of $0.30 per share payable November 30, 2024, to holders of record on November 15, 2024
Universal Technical Institute reported fiscal 2024 fourth-quarter and full-year results, with revenue and net income both higher than the prior year. The company also set fiscal 2025 guidance calling for revenue of $800-815 million and net income of $52-56 million, which would be increases over fiscal 2024 results. Adjusted free cash flow guidance of $58-62 million is below the $73.5 million reported for fiscal 2024, and beginning in fiscal 2025 growth investments will no longer be added back to Adjusted EBITDA.
Fourth-quarter revenue rose 15.3% to $196.4 million; net income was $18.8 million versus $6.7 million a year earlier.
Fiscal 2024 revenue was $732.7 million, up 20.6%, and net income was $42.0 million; diluted EPS was $0.75 versus $0.13.
Fiscal 2025 guidance: revenue $800-815 million, net income $52-56 million, diluted EPS $0.93-1.01, Adjusted EBITDA $120-124 million.
Fiscal 2025 adjusted free cash flow guidance is $58-62 million, down from $73.5 million in fiscal 2024, and assumes about $55 million of total capex.
Williams-Sonoma reported third-quarter 2024 results for the quarter ended October 27, 2024. Net revenues fell to $1.80 billion from $1.85 billion and comparable brand revenue declined 2.9%, but diluted EPS rose 7.1% to $1.96 on an operating margin of 17.8%, and the company raised its full-year 2024 outlook. The board also approved a new $1 billion stock repurchase authorization, and the raised margin guidance includes a $49 million out-of-period freight expense adjustment.
Net revenues were $1.80 billion versus $1.85 billion a year earlier; comparable brand revenue fell 2.9%.
Diluted EPS was $1.96 versus $1.83; operating margin was 17.8% versus 17.0%.
Full-year 2024 net revenue decline is now expected at -3.0% to -1.5%, and operating margin at 18.4% to 18.8%, including a $49 million out-of-period adjustment.
A new $1 billion stock repurchase authorization was approved in September 2024; total authorization is $1.3 billion, including $293 million remaining under the March 2024 program.
Powell Industries reported fiscal fourth-quarter and full-year 2024 results for the period ended September 30, 2024, with revenue and net income up sharply from the prior year. Q4 revenue was down 5% from the third quarter, and full-year net new orders fell to $1.1 billion from $1.4 billion. The filing gives no numeric fiscal 2025 guidance; management only said it expects fiscal 2025 to be another successful year.
Q4 revenue of $275 million, up 32% from $208.6 million; diluted EPS of $3.77 vs. $2.17 a year earlier
Full-year revenue of $1.0 billion, up 45%; net income of $149.8 million, or $12.29 per diluted share, up 175%
Backlog of $1.3 billion at September 30, 2024, essentially unchanged from June 30, 2024 and September 30, 2023
Conference call scheduled for Wednesday, November 20, 2024 at 11:00 a.m. Eastern time
StoneX Group reported fiscal fourth-quarter 2024 results, with net income of $76.7 million, up 51%, and diluted EPS of $2.32, up 48%, for the quarter ended September 30, 2024. For the full fiscal year, net income rose 9% to $260.8 million and diluted EPS rose 7% to $7.96, which the company called a record annual result. Results were strong across most segments, though the company noted relatively low market volatility.
Q4 net operating revenues rose 13% to $454.8 million; quarterly net income was $76.7 million, up 51% from $50.7 million a year earlier
Quarterly diluted EPS was $2.32 versus $1.57 a year earlier; ROE was 18.5% for the quarter
Full-year net income was $260.8 million, up 9%; full-year diluted EPS was $7.96, up 7%
Institutional segment operating revenues rose 30% to $554.1 million in the quarter; OTC derivatives operating revenues fell 23%
Dolby reported fourth-quarter fiscal 2024 revenue of $305 million, up from $291 million a year earlier, and GAAP diluted earnings of $0.61 per share versus $0.09. For the full fiscal year, revenue fell to $1.27 billion from $1.30 billion, while GAAP diluted EPS rose to $2.69 from $2.05. The company also gave fiscal 2025 revenue guidance of $1.33 billion to $1.39 billion and entered a $250 million revolving credit facility with Bank of America, with no amount drawn at closing.
Q4 fiscal 2024 revenue $305 million vs. $291 million a year earlier; GAAP diluted EPS $0.61 vs. $0.09
Full fiscal 2024 revenue $1.27 billion vs. $1.30 billion; GAAP diluted EPS $2.69 vs. $2.05
Fiscal 2025 guidance: total revenue $1.33 billion to $1.39 billion; GAAP diluted EPS $2.43 to $2.58
Credit Agreement signed November 14, 2024: $250 million unsecured revolver plus $150 million uncommitted incremental capacity; $0.33 per share dividend payable December 10, 2024
La-Z-Boy reported fiscal second-quarter 2025 results for the period ended October 26, 2024. Sales rose 2% to $521 million and GAAP diluted EPS rose to $0.71 from $0.63, but non-GAAP diluted EPS fell to $0.71 from $0.74 and non-GAAP operating margin declined to 7.5% from 7.9%. The board also raised the quarterly dividend 10% to $0.22 per share and guided third-quarter sales to $505 million to $525 million.
Sales of $521 million, up 2% from $511 million a year earlier; Retail segment delivered sales rose 3% to $222 million
GAAP diluted EPS $0.71 vs. $0.63; non-GAAP diluted EPS $0.71 vs. $0.74 (down 4%)
Quarterly dividend raised 10% to $0.22 per share, payable December 16, 2024, to holders of record on December 5, 2024
Third-quarter outlook: sales of $505 million to $525 million (up 1% to 5%) and non-GAAP operating margin of 6% to 7%
Keysight reported fourth-quarter fiscal 2024 revenue of $1.29 billion, down from $1.31 billion a year earlier, and a GAAP net loss of $73 million, or $0.42 per share, driven by a $315 million tax expense tied to a new Singapore tax incentive. Non-GAAP earnings per share fell to $1.65 from $1.99, and the company guided first-quarter fiscal 2025 revenue to $1.265 billion to $1.285 billion, which matters to shareholders because the charge reduced GAAP results while revenue and adjusted earnings declined.
Q4 revenue was $1.29 billion versus $1.31 billion a year earlier; GAAP net loss was $73 million, or $0.42 per share, compared with net income of $226 million, or $1.28 per share.
Non-GAAP net income was $288 million, or $1.65 per share, compared with $352 million, or $1.99 per share, in the fourth quarter of 2023.
Fiscal 2024 revenue was $4.98 billion versus $5.46 billion; GAAP net income was $0.61 billion, or $3.51 per share.
First-quarter fiscal 2025 outlook: revenue of $1.265 billion to $1.285 billion and non-GAAP earnings per share of $1.65 to $1.71.
Energizer reported fiscal 2024 net sales of $2,887.0 million, down 2.5% from $2,959.7 million, while adjusted diluted EPS rose to $3.32 from $3.09. Reported net earnings fell to $38.1 million from $140.5 million, mainly due to a $110.6 million non-cash impairment of intangible assets. The company guided fiscal 2025 adjusted EBITDA to $625 million to $645 million and adjusted EPS to $3.45 to $3.65, and its board approved a new buyback of up to 7.5 million shares.
Fiscal 2024 net sales were $2,887.0 million, down 2.5%; organic sales declined 2.2%
Fiscal 2024 reported diluted EPS was $0.52 versus $1.94; adjusted diluted EPS was $3.32 versus $3.09
Fiscal 2025 outlook: adjusted EBITDA of $625 million to $645 million and adjusted EPS of $3.45 to $3.65
Board approved a new share repurchase program of up to 7.5 million shares on November 18, 2024, replacing the prior authorization
Jacobs reported fiscal fourth-quarter 2024 revenue of $3.0 billion, up 4.4% year over year, and GAAP EPS of $2.38, helped by $187 million in mark-to-market gains on its Amentum stock. The company also gave fiscal 2025 guidance for adjusted EPS of $5.80-$6.20, compared with fiscal 2024 adjusted EPS of $5.28, following the completed separation of its Critical Mission Solutions and Cyber & Intelligence businesses into Amentum.
Q4 revenue of $2,960,150 thousand, up 4.4%; adjusted net revenue of $2.1 billion, up 4.3%
Q4 GAAP EPS of $2.38 versus $0.63 a year earlier; adjusted EPS of $1.37, up 28.0%
FY2025 outlook: adjusted EPS of $5.80-$6.20, adjusted EBITDA margin of 13.8-14.0%
FY2024 returned $545 million to shareholders through dividends and share repurchases
ADM reported third quarter 2024 GAAP net earnings attributable to the company of $18 million, or $0.04 per diluted share, compared with $821 million, or $1.52 per share, a year earlier. The results include a $461 million non-cash impairment charge on its Wilmar equity investment, and adjusted EPS was $1.09. ADM also filed restated financial statements for fiscal 2023 and the first two quarters of 2024, which it says did not affect consolidated results, and affirmed its full-year 2024 adjusted EPS range of $4.50 to $5.00.
Revenues were $19.9 billion, down from $21.7 billion in the prior-year quarter.
Total segment operating profit was $1,037 million, down 28% from $1,446 million.
Full-year 2024 adjusted EPS guidance of $4.50 to $5.00 was affirmed, not changed.
Fourth quarter AS&O segment operating profit is expected to be lower than a year earlier; Nutrition is expected to be higher than a year earlier but lower than the third quarter.
AECOM reported fiscal fourth-quarter 2024 revenue of $4.1 billion, up 7% from a year earlier, with diluted EPS of $1.25 as reported and adjusted EPS up 26%. It guided fiscal 2025 adjusted EPS to $5.00 to $5.20 and raised its quarterly dividend 18% to $0.26 and its share repurchase authorization to $1 billion, which affects per-share returns for shareholders.
Q4 fiscal 2024 diluted EPS was $1.25 as reported, versus $0.24 a year earlier; adjusted EPS rose 26%
Full-year fiscal 2024 revenue was $16.1 billion, up 12%, and free cash flow was $708 million
Fiscal 2025 guidance includes adjusted EPS of $5.00 to $5.20 and adjusted EBITDA of $1,170 million to $1,210 million
Quarterly dividend raised to $0.26 from $0.22, payable January 17, 2025, to holders of record on January 2, 2025
ESCO Technologies reported fourth-quarter sales up 9.5% to $299 million and fiscal 2024 sales up 7.4% to $1.03 billion, with GAAP EPS of $1.32 for the quarter and $3.94 for the year. The company guided fiscal 2025 sales to $1.09 to $1.11 billion and adjusted EPS to $4.70 to $4.90, excluding the pending $550 million SM&P acquisition and a strategic review of its VACCO Space business.
Q4 2024 sales rose $26 million (9.5%) to $299 million; GAAP EPS was $1.32 and adjusted EPS was $1.46, up 16.8%.
FY 2024 sales rose 7.4% to $1.03 billion; GAAP EPS was $3.94 and adjusted EPS was $4.18.
FY 2025 guidance: sales of $1.09 to $1.11 billion and adjusted EPS of $4.70 to $4.90, excluding the SM&P acquisition and the VACCO Space review.
Q4 2024 entered orders fell 14.9% to $289 million; the company did not repurchase shares in Q4.
Sally Beauty Holdings reported fourth-quarter fiscal 2024 results for the period ended September 30, 2024, with net sales up 1.5% and GAAP diluted earnings per share of $0.46, compared with $0.39 a year earlier. For the full fiscal year, net sales fell 0.3% and GAAP diluted EPS dropped to $1.43 from $1.69, and the company issued fiscal 2025 guidance calling for flat to 2% growth in net sales and an adjusted operating margin of 8.5% to 9.0%.
Q4 fiscal 2024 GAAP diluted EPS was $0.46 vs $0.39 a year earlier; adjusted diluted EPS was $0.50 vs $0.42
Full-year fiscal 2024 net sales were $3.72 billion, down 0.3%; GAAP diluted EPS was $1.43 vs $1.69
Fiscal 2025 guidance: net sales and comparable sales flat to up 2%; full-year adjusted operating margin 8.5% to 9.0%
Q4 cash flow from operations of $111 million was used to repay the remaining $45 million ABL balance and fund $10 million in share repurchases
EZCORP reported fiscal 2024 results for the year ended September 30, 2024, with total revenues up 11% to $1,161.6 million and GAAP net income of $83.1 million, up $44.6 million from the prior year. Diluted earnings per share were $1.10, compared with $0.53, and fourth-quarter net income rose to $15.2 million from $10.3 million. Headline revenue and profit both improved, but cash and cash equivalents fell 23% to $170.5 million, and the company will discuss the results on a conference call on November 14, 2024.
Full-year total revenues rose 11% to $1,161.6 million; full-year net income was $83.1 million, up $44.6 million.
Full-year diluted EPS was $1.10 versus $0.53; on an adjusted basis, diluted EPS was $1.12 versus $0.93.
Fourth-quarter net income was $15.2 million versus $10.3 million, and diluted EPS was $0.21 versus $0.15.
Cash and cash equivalents were $170.5 million at quarter end, down 23%, mainly due to the 2024 convertible debt maturity and payoff.
Helmerich & Payne reported fiscal fourth-quarter 2024 net income of $75 million, or $0.76 per diluted share, on operating revenues of $694 million, down from $89 million, or $0.88 per share, on $698 million in the prior quarter. For fiscal 2024, net income was $344 million, or $3.43 per diluted share, compared with $434 million in fiscal 2023, and the company gave fiscal 2025 capital expenditure expectations of $290 million to $325 million, excluding the pending KCA Deutag acquisition.
Q4 fiscal 2024 net income was $75 million, or $0.76 per diluted share, versus $89 million, or $0.88 per share, in the prior quarter ended June 30, 2024
Q4 operating revenues were $694 million, compared with $698 million in the prior quarter
Fiscal 2024 net income was $344 million, or $3.43 per diluted share, versus $434 million in fiscal 2023
Fiscal 2025 capital expenditures are expected to range from $290 million to $325 million; quarterly dividend of $0.25 per share is payable December 2, 2024
J&J Snack Foods reported fiscal fourth-quarter sales down 3.9% to $426.8 million and diluted EPS down 3.2% to $1.52, compared with the prior-year quarter, which included an extra week. For the full fiscal year ended September 28, 2024, sales rose 1.0% to $1.57 billion and diluted EPS rose 9.1% to $4.45, but the company said softer consumer spending and lower quarterly gross margin weighed on the fourth quarter.
Q4 net sales $426.8 million, down 3.9% as reported and up 3.9% on a normalized basis; Q4 gross margin 31.8%, down 110 basis points
Full-year net earnings $86.6 million, up 9.7%; full-year diluted EPS $4.45, up 9.1%; adjusted EPS $4.93, up 9.6%
Q4 operating income $39.8 million, down 4.5%; Q4 net earnings $29.6 million, down 2.6%
Management will discuss results and business outlook on a conference call on November 14, 2024, at 10:00 a.m. Eastern Time
StandardAero reported third quarter 2024 revenue of $1.24 billion, up 13.2% from a year earlier, and net income of $16.4 million, compared with a net loss of $17.9 million in the prior-year quarter. Adjusted EBITDA rose 26.0% to $168.4 million, and the company said its October 2024 IPO and debt refinancing are expected to produce more than $130 million in annual interest savings compared with pre-IPO levels.
Revenue was $1.24 billion ($1,244.6 million), up 13.2% from $1.10 billion a year earlier, led by commercial aerospace (up 20%) and business aviation (up 15%).
Net income was $16.4 million, or $0.06 per share, versus a net loss of $17.9 million, or $(0.06) per share, in the prior-year quarter.
Adjusted EBITDA was $168.4 million, up 26.0%, with margin of 13.5%, up 137 basis points.
The IPO closed October 2, 2024 at $24.00 per share, with about $1.2 billion of net proceeds used to repay debt; new credit facilities were put in place October 31, 2024.
Digi International reported fiscal fourth-quarter revenue of $105 million, down 6% from a year earlier, and full-year fiscal 2024 revenue of $424 million, down 5%. GAAP net income rose in the quarter to $12 million but fell for the full year to $23 million, while adjusted EPS was flat at $0.52 for the quarter and $1.99 for the year. The company guided fiscal 2025 revenue and adjusted EBITDA to be flat year over year, with ARR projected to grow about 10%.
Q4 revenue $105 million, down 6%; Q4 diluted EPS $0.32 vs. $0.17; full-year diluted EPS $0.61 vs. $0.67
Q4 gross profit margin 61.1%, up 400 basis points; ARR at quarter end $116 million, up 9%
Fiscal 2025 outlook: revenue and adjusted EBITDA flat; ARR projected to grow approximately 10%
First quarter fiscal 2025 guidance: revenue $102 million to $106 million; adjusted EPS $0.46 to $0.50
Tetra Tech reported record revenue of $5.20 billion for fiscal 2024, up 15% from the prior year, and diluted EPS of $1.23, up 21%. The company also gave fiscal 2025 guidance of $1.40 to $1.50 in EPS and declared a $0.058 per share quarterly dividend, a 12% increase year over year.
Fiscal 2024 operating income was $501 million, up 40% year over year; fourth-quarter diluted EPS was $0.35, up 75%.
Fiscal 2025 guidance: net revenue of $4.565 billion to $4.765 billion and EPS of $1.40 to $1.50.
Quarterly dividend of $0.058 per share is payable December 13, 2024, to holders of record on November 27, 2024.
$348 million remained under the company's $400 million share repurchase program.
Kulicke and Soffa reported fiscal fourth-quarter 2024 net revenue of $181.3 million, down 10.4% from a year earlier, with GAAP net income of $12.1 million, or $0.22 per diluted share, down 46.3%. For the first quarter of fiscal 2025, the company expects net revenue of about $165.0 million, plus or minus $10 million, and non-GAAP diluted EPS of about $0.28, which includes a claim or proceeds from the cessation of business related to Project W.
Q4 fiscal 2024 net revenue $181.3 million, down 10.4% year over year; GAAP diluted EPS $0.22 versus $0.41 a year earlier
Non-GAAP diluted EPS $0.34, down 33.3% year over year; fiscal 2024 net loss of $69.0 million, or $(1.24) per share, including $44.5 million in impairment charges
Q1 fiscal 2025 outlook: net revenue about $165.0 million, +/- $10 million; GAAP diluted EPS about $1.45, including a $75.0 million claim or proceeds item; non-GAAP diluted EPS about $0.28
Company repurchased 3.2 million shares for $151.0 million in fiscal 2024; cash and short-term investments were $577.1 million as of September 28, 2024
Griffon reported fiscal 2024 revenue of $2.6 billion, down 2% from the prior year, while net income rose to $209.9 million from $77.6 million. Fourth-quarter revenue grew 3% to $659.7 million, and the board approved a $400 million share buyback and a 20% dividend increase, which the company says reflects its confidence in its outlook.
Fiscal 2024 revenue $2.6 billion, down 2% from $2.7 billion; fourth-quarter revenue $659.7 million, up 3%
Fiscal 2024 net income $209.9 million, or $4.23 per share, versus $1.42 per share a year earlier; fourth-quarter EPS $1.29 versus $0.79
Board approved a $400 million share buyback and raised the regular quarterly dividend 20% to $0.18 per share
Fiscal 2025 outlook: revenue consistent with 2024 at $2.6 billion; adjusted EBITDA $575 million to $600 million
Liquidia reported third quarter 2024 revenue of $4.4 million, up from $3.7 million a year earlier, while its net loss widened to $23.2 million, or $0.30 per share, from $15.8 million, or $0.24 per share. Operating expenses rose sharply, with general and administrative expenses up 91% to $20.2 million, though a $7.2 million gain on debt extinguishment reduced the net loss. Cash and cash equivalents were $204.4 million as of September 30, 2024, and the company said its recent capital raises strengthened the balance sheet.
Revenue was $4.4 million for the quarter ended September 30, 2024, compared with $3.7 million a year earlier, mainly from the Sandoz promotion agreement.
Net loss was $23.2 million, or $0.30 per share, compared with a net loss of $15.8 million, or $0.24 per share, a year earlier.
General and administrative expenses rose 91% to $20.2 million, and research and development expenses rose 60% to $11.9 million.
Cash and cash equivalents totaled $204.4 million at September 30, 2024, up from $83.6 million at December 31, 2023.
RadNet reported third quarter 2024 revenue of $461.1 million, up 14.7%, and Adjusted EBITDA of $73.7 million, up 27.2%, with Adjusted diluted EPS of $0.18 versus $0.13. GAAP net income attributable to common stockholders fell to $3.2 million ($0.04 per diluted share) from $17.5 million ($0.25), and the company raised its Imaging Center revenue and Adjusted EBITDA guidance for 2024.
Q3 2024 Total Company Revenue was $461.1 million, up from $402.0 million; Adjusted EBITDA was $73.7 million, up from $57.9 million.
GAAP net income attributable to RadNet common stockholders was $3.2 million, or $0.04 per diluted share, versus $17.5 million, or $0.25, in Q3 2023; the company cited an $8.1 million non-cash loss from interest rate swaps among one-time ite
Adjusted diluted EPS was $0.18 versus $0.13 a year earlier.
Imaging Center 2024 guidance now projects Total Net Revenue of $1,710 - $1,760 million (up from $1,685 - $1,735 million) and Adjusted EBITDA of $262 - $270 million (up from $257 - $267 million).
CAVA Group reported fiscal third-quarter 2024 results for the period ended October 6, 2024, with CAVA segment revenue up 39.0% and net income rising to $18.0 million from $6.8 million a year earlier. The company also raised its fiscal 2024 guidance, lifting its Adjusted EBITDA forecast to $121.0 million to $126.0 million from $109.0 million to $114.0 million.
CAVA Revenue grew 39.0% to $241.5 million, versus $173.8 million in the prior-year quarter.
Net income was $18.0 million, or $0.15 per diluted share, compared with $6.8 million, or $0.06 per diluted share, a year earlier.
Fiscal 2024 guidance raised: CAVA Same Restaurant Sales Growth to 12.0% to 13.0% from 8.5% to 9.5%, and Adjusted EBITDA to $121.0 million to $126.0 million from $109.0 million to $114.0 million.
CAVA Restaurant-Level Profit Margin was 25.6%, compared with 25.1% in the prior-year quarter.
ePlus reported fiscal second-quarter results for the three months ended September 30, 2024, with net sales down 12.3% and diluted earnings per share down to $1.17 from $1.22. Consolidated gross profit rose 2.5%, helped by services and financing revenue, and the company now expects fiscal 2025 net sales similar to fiscal 2024 and adjusted EBITDA of $195 million to $205 million.
Q2 net sales fell 12.3% to $515.2 million; product sales fell 22.2% to $389.6 million, while services revenue rose 46.0% to $103.7 million
Consolidated gross profit rose 2.5% to $148.0 million, and gross margin was 28.7%, compared with 24.6% a year earlier
Net earnings fell 4.1% to $31.3 million; adjusted EBITDA fell 2.7% to $52.1 million
Fiscal 2025 guidance: net sales now expected to be similar to fiscal 2024; adjusted EBITDA now expected at $195 million to $205 million
Rocket Lab reported third-quarter 2024 results on November 12, 2024. Revenue rose 55% year over year to $104.8 million, but the net loss widened to $51.9 million from $40.6 million, and the adjusted EBITDA loss grew to $30.9 million from $15.5 million. The company guided fourth-quarter revenue to $125 million to $135 million, which it describes as a record quarter.
Q3 2024 revenue was $104.8 million, up from $67.7 million in Q3 2023.
Net loss was $51.9 million, or $0.10 per share, compared with $40.6 million, or $0.08 per share, a year earlier.
Q4 2024 guidance calls for revenue of $125 million to $135 million and GAAP gross margins of 26% to 28%.
CEO Sir Peter Beck cited a backlog of $1.05 billion.
BioLife Solutions reported unaudited third-quarter 2024 revenue of $30.6 million, up 30% from a year earlier, and a GAAP net loss from continuing operations of $1.7 million, down from $15.8 million. The company also completed the $73.0 million cash sale of its SciSafe biostorage subsidiary on November 12, 2024, and cut its full-year 2024 total revenue guidance to $98.0 million to $100.0 million from $99.0 million to $101.0 million, citing the divestiture.
Q3 2024 total revenue was $30.6 million, up from $23.6 million in Q3 2023 and up 8% sequentially.
Q3 2024 GAAP net loss from continuing operations was $1.7 million, or $0.04 per share, versus $15.8 million, or $0.36 per share, a year earlier.
Adjusted EBITDA was $6.1 million, or 20% of revenue, compared with $1.4 million, or 6%, in Q3 2023.
Cell Processing 2024 revenue guidance was raised to $72.0 million to $73.0 million, while Biostorage Services guidance was lowered to $26.0 million to $27.0 million.
Dave Inc. reported third-quarter 2024 revenue of $92.5 million, up 41% from a year earlier, and net income of $0.5 million, compared with a net loss of $12.1 million in the same quarter of 2023. The company raised its full-year 2024 revenue guidance to $340 million to $343 million and its Adjusted EBITDA guidance to $71 million to $74 million, which is a positive signal for shareholders on both growth and profitability.
Q3 2024 revenue was $92.5 million, up 41% year over year, and net income was $0.5 million versus a $12.1 million loss in Q3 2023.
Q3 2024 Adjusted EBITDA was $24.7 million, compared with a $2.5 million loss in Q3 2023.
Full-year 2024 revenue guidance was raised to $340 million to $343 million from $310 million to $325 million.
Full-year 2024 Adjusted EBITDA guidance was raised to $71 million to $74 million from $40 million to $50 million.
ICU Medical reported third quarter 2024 revenue of $589.1 million, up from $553.3 million a year earlier, but swung to a GAAP net loss of $33.0 million from net income of $7.2 million. The company also widened its full-year 2024 GAAP net loss outlook, while narrowing its adjusted EBITDA range, so shareholders face a mixed picture on reported results and updated guidance.
Q3 2024 revenue was $589.1 million, up from $553.3 million in Q3 2023.
GAAP net loss was $33.0 million, or $1.35 per diluted share, versus net income of $7.2 million, or $0.30 per share, a year earlier.
Adjusted diluted EPS was $1.59 versus $1.57, and adjusted EBITDA was $94.8 million versus $89.8 million.
FY2024 GAAP net loss outlook moved to $122 million to $130 million from $108 million to $118 million; adjusted EBITDA outlook is now $355 million to $365 million.
NCR Atleos reported third quarter 2024 results on November 12, 2024. Revenue was $1.08 billion, up from $1.07 billion a year earlier, and GAAP net income attributable to Atleos was $24 million, compared with a net loss of $58 million a year earlier. The company reaffirmed its full-year 2024 guidance and said non-GAAP EPS guidance moved to the high end of its range, which matters to shareholders because it signals results ahead of the company's prior expectations.
Q3 revenue $1.08 billion vs. $1.07 billion a year earlier; Adjusted EBITDA $207 million vs. $210 million
GAAP diluted EPS $0.32 vs. loss of $0.82 a year earlier; non-GAAP diluted EPS $0.89
Full-year 2024 non-GAAP diluted EPS guidance of approximately $3.12, versus previous range of $2.90 to $3.20
October 17, 2024 debt refinancing reduced spread to SOFR by about 100 basis points on roughly $1.7 billion of variable rate debt
ZoomInfo reported third quarter 2024 results with GAAP revenue of $303.6 million, down 3% from a year earlier, and GAAP operating income of $43.5 million, down 31%. It raised its full-year 2024 adjusted net income per share guidance to $0.92-$0.93, from $0.86-$0.88 previously, while narrowing its full-year revenue guidance to $1.201-$1.204 billion.
Q3 2024 GAAP revenue was $303.6 million, down 3% year over year; GAAP diluted EPS was $0.07 versus $0.08 a year earlier.
Adjusted net income per share rose to $0.28 from $0.26, and adjusted operating income was $111.7 million, down 11%.
Full-year 2024 adjusted EPS guidance was raised to $0.92-$0.93; GAAP revenue guidance is $1.201-$1.204 billion, versus $1.190-$1.205 billion previously.
The company repurchased 24,478,696 shares for $242.1 million in the quarter, and has repurchased about 17% of outstanding shares since a buyback began in March 2023.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.